Article
A single point mutation in the Plasmodium falciparum 3'-5' exonuclease does not alter piperaquine susceptibility.
Malaria journal - 22 Apr 2022
Boonyalai Nonlawat, Kirativanich Kirakarn, Thamnurak Chatchadaporn, Praditpol Chantida, Vesely Brian A, Wojnarski Mariusz, Griesenbeck John S, Waters Norman C
Abstract excerpt
BACKGROUND: The rise in Plasmodium falciparum resistance to dihydroartemisinin-piperaquine (DHA-PPQ) treatment has been documented in the Greater Mekong Subregion with associations with mutations in the P. falciparum chloroquine resistance transporter (pfcrt) and plasmepsin 2 (pfpm2) genes. However, it is unclear whether other genes also play a role with PPQ resistance, such as the E415G mutation in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
